Chemotherapy
Personalized Adaptive Novel Agents for Breast Cancer
Recruiting1 awardPhase 2
Birmingham, Alabama
This trial is testing new medicines along with regular cancer treatment to find the best combinations for breast cancer patients. It focuses on identifying which treatments work best based on specific cancer characteristics. Early signs of success are monitored using MRI scans and tests on blood and tissue samples.
Checkpoint Inhibitor
Oleclumab + Durvalumab for Advanced Sarcoma
Recruiting1 awardPhase 2
Houston, Texas
This trial is testing two immunotherapy drugs, oleclumab and durvalumab, in patients with difficult-to-treat sarcoma. These drugs help the immune system to find and destroy cancer cells and may stop the cancer from growing and spreading.
Popular Filters
Trials for Hemangiosarcoma Patients
Alkylating agents
Combination Therapy for Soft Tissue Sarcoma
Recruiting1 awardPhase 1 & 2
Memphis, Tennessee
This trial aims to study the treatment of non-rhabdomyosarcoma soft tissue sarcoma in both intermediate-risk and high-risk patients. The primary objectives include assessing the survival rates and pharmacokin
Monoclonal Antibodies
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody for Advanced Cancer
Recruiting1 awardPhase 1
Scottsdale, Arizona
This trial is testing two new drugs that help the immune system fight cancer. It targets adults with advanced cancers that haven't responded to other treatments. The drugs work by blocking proteins that usually prevent the immune system from attacking cancer cells.
Trials for HSA Patients
Alkylating agents
Combination Therapy for Soft Tissue Sarcoma
Recruiting1 awardPhase 1 & 2
Memphis, Tennessee
This trial aims to study the treatment of non-rhabdomyosarcoma soft tissue sarcoma in both intermediate-risk and high-risk patients. The primary objectives include assessing the survival rates and pharmacokin
Monoclonal Antibodies
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody for Advanced Cancer
Recruiting1 awardPhase 1
Scottsdale, Arizona
This trial is testing two new drugs that help the immune system fight cancer. It targets adults with advanced cancers that haven't responded to other treatments. The drugs work by blocking proteins that usually prevent the immune system from attacking cancer cells.
Trials With No Placebo
Alkylating agents
Combination Therapy for Soft Tissue Sarcoma
Recruiting1 awardPhase 1 & 2
Memphis, Tennessee
This trial aims to study the treatment of non-rhabdomyosarcoma soft tissue sarcoma in both intermediate-risk and high-risk patients. The primary objectives include assessing the survival rates and pharmacokin
Monoclonal Antibodies
Sintilimab for Angiosarcoma
Recruiting1 awardPhase 2
Houston, Texas
This trial tests sintilimab, an immunotherapy drug, in patients with advanced, metastatic, or recurrent angiosarcoma. Sintilimab helps the immune system recognize and attack cancer cells, aiming to control the disease.
Anti-microtubule agent
Nivolumab + Chemotherapy for Soft Tissue Sarcoma
Recruiting1 awardPhase 2
Phoenix, Arizona
This trial is testing the effectiveness of two drugs, paclitaxel and cabozantinib, in treating patients with soft tissue sarcoma. The first group of patients will receive paclitaxel, and the second group will receive paclitaxel and cabozantinib. The trial is being done to see if the combination of the two drugs can shrink the tumor and prevent it from coming back.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.